FDA moves to review allowing pharmacies to make BPC-157, TB-500, KPV
The agency is set to revisit peptide production, but evidence and safety data remain thin.
By Nora Al-Subaie·· 4 min
Loading the Newsroom
Curating from trusted global sources…
Curating from trusted global sources…
1 briefing · “tb-500”
The agency is set to revisit peptide production, but evidence and safety data remain thin.